Mirum Pharmaceuticals, Inc. (MIRM)
96.74
+0.44
(+0.45%)
USD |
NASDAQ |
Aug 24, 16:00
96.74
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Market Cap : 6.265B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 6.237B |
| August 20, 2026 | 6.286B |
| August 19, 2026 | 6.621B |
| August 18, 2026 | 6.532B |
| August 17, 2026 | 6.464B |
| August 14, 2026 | 6.517B |
| August 13, 2026 | 6.396B |
| August 12, 2026 | 6.409B |
| August 11, 2026 | 6.361B |
| August 10, 2026 | 6.391B |
| August 07, 2026 | 6.518B |
| August 06, 2026 | 6.094B |
| August 05, 2026 | 6.850B |
| August 04, 2026 | 6.756B |
| August 03, 2026 | 6.372B |
| July 31, 2026 | 6.455B |
| July 30, 2026 | 6.860B |
| July 29, 2026 | 6.554B |
| July 28, 2026 | 6.838B |
| July 27, 2026 | 6.958B |
| July 24, 2026 | 6.886B |
| July 23, 2026 | 6.968B |
| July 22, 2026 | 6.975B |
| July 21, 2026 | 7.131B |
| July 20, 2026 | 7.105B |
| Date | Value |
|---|---|
| July 17, 2026 | 7.242B |
| July 16, 2026 | 7.150B |
| July 15, 2026 | 7.372B |
| July 14, 2026 | 7.365B |
| July 13, 2026 | 7.253B |
| July 10, 2026 | 7.441B |
| July 09, 2026 | 7.780B |
| July 08, 2026 | 7.833B |
| July 07, 2026 | 7.817B |
| July 06, 2026 | 7.428B |
| July 02, 2026 | 7.652B |
| July 01, 2026 | 7.339B |
| June 30, 2026 | 7.133B |
| June 29, 2026 | 7.494B |
| June 26, 2026 | 7.541B |
| June 25, 2026 | 7.145B |
| June 24, 2026 | 7.005B |
| June 23, 2026 | 6.767B |
| June 22, 2026 | 6.566B |
| June 18, 2026 | 6.527B |
| June 17, 2026 | 6.217B |
| June 16, 2026 | 6.187B |
| June 15, 2026 | 6.154B |
| June 12, 2026 | 6.053B |
| June 11, 2026 | 6.065B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Incyte Corp. | 25.72B |
| Insmed, Inc. | 27.07B |
| Alnylam Pharmaceuticals, Inc. | 31.57B |
| BioMarin Pharmaceutical, Inc. | 12.59B |
| Ionis Pharmaceuticals, Inc. | 10.27B |
Market Cap Related Metrics
| PS Ratio | 9.033 |
| PEG Ratio | -0.0060 |
| Price | 96.74 |
| Earnings Yield | -15.04% |
| PEGY Ratio | -0.0060 |